{"cmr":"ch-cm-kg/BX/1CG","since":null,"total":25,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"ch-cm-kg/BX/1CG","date":"2026-11-04","event_type":"newswire_release","title":"CRISPR Therapeutics to Present Clinical Data from Zugo-cel","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/11/04/3395391/0/en/crispr-therapeutics-to-present-clinical-data-from-zugo-cel-in-large-b-cell-lymphoma-at-the-68th-american-society-of-hematology-ash-annual-meeting-and-exposition.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"86S7nHb2gggwvbx4OSLIclPFe3S7RmNqTqaWdHPTFE7PEisff7feH5fbdkJDOBErHpBlQ9VrsQYyEx5Zohw0CA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-11-02","event_type":"newswire_release","title":"CRISPR Therapeutics Announces the Appointment of Siva","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/11/02/3393099/0/en/crispr-therapeutics-announces-the-appointment-of-siva-sakhamuri-ph-d-as-chief-technical-officer.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"xaWkB_MQkgIYZ5tN7e0SOBPEMZgzHC7d-QqfLVJbzWuFh6tTXmiu1TdYm088AnwC7NvQNmD69JlCtcPMJo2yBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-11-02","event_type":"newswire_release","title":"CRISPR Therapeutics Provides Business Update and Reports","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/11/02/3393703/0/en/crispr-therapeutics-provides-business-update-and-reports-third-quarter-2026-financial-results.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"V-9LDWdgmAseYXME7iz3PyhGF0VHWrUCrGs4rsRYZF8hvDjCIA2X0pTkoAUDHmoIcCrBjfjDWqBO1yVpl0f3BQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-10-08","event_type":"newswire_release","title":"CRISPR Therapeutics to Present Late-Breaking Data at the","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/08/3377269/0/en/crispr-therapeutics-to-present-late-breaking-data-at-the-american-heart-association-aha-scientific-sessions-2026.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"i_NiXynG0dQcA355r9ivOV3ijHWChxtEIY-u9-OVghrrLUlG8ApGva1d6yxwdepKHA0auiZKwNMcHhFJ8v7uDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-10-02","event_type":"newswire_release","title":"CRISPR Therapeutics to Present Clinical Data on","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/02/3373871/0/en/crispr-therapeutics-to-present-clinical-data-on-zugocabtagene-geleucel-zugo-cel-in-autoimmune-disease-at-the-american-college-of-rheumatology-acr-convergence-2026.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"2XyOvYhEuh9matWW3hg7xaYoUjKaLIsrFU9nzVew4qeVb84gmYhGDdvkpAO7b9oG4H2SNYzE8ciNivPeJO4MDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-09-08","event_type":"newswire_release","title":"CRISPR Therapeutics to Present at the Morgan Stanley 24th","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/08/3357662/0/en/crispr-therapeutics-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5rMUdsG81wtJIW1vuyu_gTqL9Koan2H-iiIaqFzZESLRT0cnYUl4VPFwgCw153IGDzHj4H5l4RubPzxSzilVDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-08-28","event_type":"newswire_release","title":"CRISPR Therapeutics Presents Phase 1a Data for CTX310®","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/08/28/3352748/0/en/crispr-therapeutics-presents-phase-1a-data-for-ctx310-demonstrating-deep-and-durable-angptl3-editing-triglyceride-and-ldl-lowering-at-esc-congress-2026.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Irn-qr6qsjckVLQz2YABRGnFKsIr74xJdosO70kaZXE1r4vNimiubZ7eAnfJwcRdTHkK8qlfzfxLrIKSSTzqAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-08-03","event_type":"newswire_release","title":"CRISPR Therapeutics Provides Business Update and Reports","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/08/03/3337896/0/en/crispr-therapeutics-provides-business-update-and-reports-second-quarter-2026-financial-results.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"1JPC8a4oKiALLzV3b3jKnuMqoaDjIQk9wrsh1cAqQKQht03zvhadhO-njhePIRa6L0WRUNXlM9R4kxx_4xcACA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-06-11","event_type":"register_mutation","title":"HR02 Change CRISPR Therapeutics AG, Zug","reference":"HR02-1006673851","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/49d3c6fc-68da-44fe-b43c-d7249ae44cdd","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006673851; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"LF8ml2k91SbbQZk0tT3he-2kGs2mCpx80AL8zIyZvv9UvW6SVmLply_VMWx2hrmqO7iKLsthtl49nMmE5c23Bw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-05-28","event_type":"newswire_release","title":"CRISPR Therapeutics to Participate in Upcoming Investor Conferences","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/05/28/3302788/0/en/crispr-therapeutics-to-participate-in-upcoming-investor-conferences.html","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"HDW8Ly5uCtou7HRxf0DrxIGYJuMFnUhrFPclXGRrOZ5zq75J-tJLY8zmK6Qh-9PXI-oB3w9P6Xa7_FBlvienDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-05-06","event_type":"newswire_release","title":"CRISPR Therapeutics to Present at the Bank of America","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/05/06/3288816/0/en/CRISPR-Therapeutics-to-Present-at-the-Bank-of-America-Securities-2026-Global-Healthcare-Conference.html","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"aA_di3_MPV_jcJBwGv1eEVlT6ZihOwS5hvBR_LbQPXGQkdrkV9kFiCFP-na-k9kMcrwSQkP0vnVLBclg85tbBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-05-04","event_type":"newswire_release","title":"CRISPR Therapeutics Provides Business Update and Reports","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/05/04/3287176/0/en/crispr-therapeutics-provides-business-update-and-reports-first-quarter-2026-financial-results.html","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"6H7iwLNg_FjKUifSl9YgqRYY4N68HM1wSntecMV8_XmTBfSQ_BOxnNBcdp2W7GaWq0tSXh6_1BrJicEgpH5JDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-04-07","event_type":"newswire_release","title":"CRISPR Therapeutics to Present at the 25th","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/04/07/3269071/0/en/CRISPR-Therapeutics-to-Present-at-the-25th-Annual-Needham-Virtual-Healthcare-Conference.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"FThSXPeDzs2kTLGsTgD3AH7UHt8W9tRtBAhtTAuvBCIoB90nPg6FkuqEhp235ld4P_xKi7gDvq3_sMe2ZHNwAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-03-30","event_type":"register_mutation","title":"HR02 Change CRISPR Therapeutics AG, Zug","reference":"HR02-1006610619","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/122646f9-727b-4488-bea0-03935f847421","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006610619; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"zb6W5S7e32wUYNFelw2u4DXLMtyaWPMKDgmWbPFHp1jT5NXzSmS5X64Vl3M_DhN7RyOe3e4L-z7J9RWXt-stBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-03-10","event_type":"newswire_release","title":"CRISPR Therapeutics Announces Proposed Convertible Senior","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/03/10/3252625/0/en/crispr-therapeutics-announces-proposed-convertible-senior-notes-offering.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"k_pOrVA86O6NRhr8v-zd2onYbHEzEI9n94r0ORV4CKnZ684KgTzuPnF1sarjpM_FCiOKmtIHGkUHdR9yB7iaAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-03-10","event_type":"newswire_release","title":"CRISPR Therapeutics Announces Proposed Convertible Senior","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/fr/news-release/2026/3/10/3252625/0/en/CRISPR-Therapeutics-Announces-Proposed-Convertible-Senior-Notes-Offering.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"LekUVBdr6GunQHqXJvkr4kAYkq6XKAQYB4H2amCnEcK3VExNS2CUxNEZFmZ7Wk4A6wJf04BvaIGcJCBGvsoBDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-01-12","event_type":"newswire_release","title":"CRISPR Therapeutics Highlights Strategic Priorities and","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/01/12/3216929/0/en/crispr-therapeutics-highlights-strategic-priorities-and-anticipated-2026-milestones.html","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"2FCCUfZhEhOTAanKvnZRPf7GnN9_i95h5s-ABFTIU8xiKd7rEPsZ2Gk03MBR316OHyhhR7Z5r7H28WjK2l7BBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-01-12","event_type":"newswire_release","title":"CRISPR Therapeutics Highlights Strategic Priorities and","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/01/12/3216929/0/en/CRISPR-Therapeutics-Highlights-Strategic-Priorities-and","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"C-VDxuQU4ObOrjZHkj9IZFLVeDbIWQnwkrhlh0pQsCCcV6fEW-5zebWA_NULSK8NRxY3n5hDzaofQVM1rXOvCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2026-01-05","event_type":"newswire_release","title":"CRISPR Therapeutics to Present at the 44th Annual J.P.","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/01/05/3212778/0/en/CRISPR-Therapeutics-to-Present-at-the-44th-Annual-J-P-Morgan-Healthcare-Conference.html","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"XNA4PMst7od-mEeMgVdBP6IsFt27TKmqfyW8DrNvfBV0Snjxgde5K2sLJpQD8t9UrCS1t7ZcUrenNH23Xt-5Bg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2025-11-17","event_type":"newswire_release","title":"CorriXR Therapeutics Announces Publication of Preclinical Data Demonstrating Potential of CRISPR-Directed Gene Editing to Overcome Drug Resistance in Solid Tumors","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251117450095/en/CorriXR-Therapeutics-Announces-Publication-of-Preclinical-Data-Demonstrating-Potential-of-CRISPR-Directed-Gene-Editing-to-Overcome-Drug-Resistance-in-Solid-Tumors","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"AdSizRhNZVk3JIPkTOc8xEWxp5h_yW0txM-Ue24qJCReyTHa8dTHYz0xKGGxULzsx3M-22-WVg4DDuCsuZb7Cw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2025-11-10","event_type":"newswire_release","title":"CRISPR Therapeutics Provides Business Update and Reports","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/11/10/3184507/0/en/CRISPR-Therapeutics-Provides-Business-Update-and-Reports-Third-Quarter-2025-Financial-Results.html","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"4-EYirDknIuGfmsEGgniRAoMGTmkfO_ukq9zohesX1hhpk5P2qmso-Bcm-COPUKQaHIwdsn0L9N52upFJ-4zAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2025-11-08","event_type":"newswire_release","title":"CRISPR Therapeutics Announces Positive Phase 1 Clinical","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/11/08/3184062/0/en/CRISPR-Therapeutics-Announces-Positive-Phase-1-Clinical-Data-for-CTX310-Demonstrating-Deep-and-Durable-ANGPTL3-Editing-Triglyceride-and-Lipid-Lowering.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ElQ7rN-pRui66hW3TEZIZr7w6bJGH1WRHEWDcXtz41hXo3M-8rIvWrQ1sVD578Obha0a8FF_DgSLuUbXnJI0DQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2025-10-17","event_type":"register_mutation","title":"HR02 Change CRISPR Therapeutics AG, Zug","reference":"HR02-1006460952","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/442c9d54-24c5-471c-b9fb-9f8b53ce6f1c","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006460952; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"NaIWR1GkL3vMb8d7To-iJfGqQ9zHrQXM0gHc-P4b1uDEo0sVGG5x_4t3RXcUeuktTcpClGVJppOBeIby_mLRBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2025-09-22","event_type":"newswire_release","title":"CRISPR Therapeutics and Sirius Therapeutics Announce First","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/09/22/3153917/0/en/CRISPR-Therapeutics-and-Sirius-Therapeutics-Announce-First-Patient-Dosed-in-Phase-2-Trial-of-SRSD107-for-Thromboembolic-Disorders-in-Europe.html","read_by":"Tavily search (wire domains) + published_date · adjudicated by Claude","state":"sourced","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"pGbrNkzontk8tVnNPbUQqGebimfD-VKrOqxsqdWIH1shbudQ339A4tcZRFXxsRbUiAzLgu7alrH8y2S6-yD4BA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ch-cm-kg/BX/1CG","date":"2025-09-18","event_type":"register_mutation","title":"HR02 Change CRISPR Therapeutics AG, Zug","reference":"HR02-1006436326","category":"HR02","language":"de","source":"SHAB / FOSC commercial register publication","url":"https://www.shab.ch/#!/search/publications/detail/fc6d7d36-497e-4a91-88f0-508bdba58e5b","read_by":"SHAB publications API (Swiss Official Gazette of Commerce, commercial-register rubric)","detail":"publication HR02-1006436326; office Bundesamt für Justiz (BJ), Eidgenössisches Amt für das Handelsregister","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"t0A2DYdNN57NoyzjuFldlKp7mVGfxqSCgC6XPrlqMoVAHaC7lBuNyVBKx9Z8vLi5via7EEdtgRdPPwsJdVA9AQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}